Skip to main content
SpringerLink
Log in

Antiepileptic-drugs

Lack of efficacy, off label use in unapproved age group and rebound effect in the form of increased seizure frequency: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Nissenkorn A, et al. Personalized treatment with retigabine for pharmacoresistant epilepsy arising from a pathogenic variant in the KCNQ2 selectivity filter. Epileptic Disorders 23: 695-705, No. 5, Oct 2021. Available from: URL: http://doi.org/10.1684/epd.2021.1315

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antiepileptic-drugs. Reactions Weekly 1937, 49 (2022). https://doi.org/10.1007/s40278-022-29729-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-29729-5

Search

Navigation